Non-invasive evaluation long-term cardiac effects captopril systemic sclerosis Impairment left ventricular LV function patients systemic sclerosis SScl intermittent vasospastic process myocardium development myocardial dysfunction Vasodilators useful treatment cardiac dysfunction patients SScl study long-term effects captopril myocardial function patients SScl Twenty-two patients SScl patients diffuse scleroderma patients CREST syndrome i.e calcinosis Raynaud phenomenon oesophageal hypomotility sclerodactyly telangiectasia means Doppler echophonocardiography treatment captopril body months significant differences heart rate systolic diastolic blood pressure end-systolic blood pressure total peripheral resistance LV diameters treatment captopril treatment significant effects LV function pre-ejection period PEP ratio pre-ejection period LV ejection time Mitral E-point septal separation adjustment LV end-diastolic diameter ejection fraction isovolumic relaxation time left atrial index Doppler peak early ventricular filling velocity isovolumic index systolic diastolic LV function indices patients SScl captopril treatment mean period year effects captopril due vasodilation myocardial vessels direct effect renin-angiotensin system heart 